Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorPei, J. (Jiayi)-
dc.creatorHarakalova, M. (Magdalena)-
dc.creatorTreibel, T.A. (Thomas A.)-
dc.creatorLumbers, R.T. (R. Thomas)-
dc.creatorBoukens, B.J. (Bastiaan J.)-
dc.creatorEfimov, I.R. (Igor R.)-
dc.creatorvan-Dinter, J.T. (Jip T.)-
dc.creatorGonzalez, A. (Arantxa)-
dc.creatorLópez, B. (Begoña)-
dc.creatorEl-Azzouzi, H. (Hamid)-
dc.creatorvan-den-Dungen, N. (Noortje)-
dc.creatorvan-Dijk, C.G.M. (Christian)-
dc.creatorKrebber, M.M. (Merle M.)-
dc.creatorden-Ruijter, H.M. (Hester M.)-
dc.creatorPasterkamp, G. (Gerard)-
dc.creatorDuncker, D.J. (Dirk J.)-
dc.creatorNieuwenhuis, E.E.S. (Edward E.S.)-
dc.creatorde-Weger, R. (Roel)-
dc.creatorHuibers, M.M. (Manon M.)-
dc.creatorVink, A. (Aryan)-
dc.creatorMoore, J.H. (Jason H.)-
dc.creatorMoon, J.C. (James C.)-
dc.creatorVerhaar, M.C. (Marianne C.)-
dc.creatorKararigas, G. (Georgios)-
dc.creatorMokry, M. (Michal)-
dc.creatorAsselbergs, F.W. (Folkert W.)-
dc.creatorCheng, C. (Caroline)-
dc.date.accessioned2023-05-23T07:55:17Z-
dc.date.available2023-05-23T07:55:17Z-
dc.date.issued2020-
dc.identifier.citationPei, J. (Jiayi); Harakalova, M. (Magdalena); Treibel, T.A. (Thomas A.); et al. "H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts". Clinical Epigenetics. 12 (106), 2020,es_ES
dc.identifier.issn1868-7075-
dc.identifier.urihttps://hdl.handle.net/10171/66327-
dc.description.abstractBackground: H3K27ac histone acetylome changes contribute to the phenotypic response in heart diseases, particularly in end-stage heart failure. However, such epigenetic alterations have not been systematically investigated in remodeled non-failing human hearts. Therefore, valuable insight into cardiac dysfunction in early remodeling is lacking. This study aimed to reveal the acetylation changes of chromatin regions in response to myocardial remodeling and their correlations to transcriptional changes of neighboring genes. Results: We detected chromatin regions with differential acetylation activity (DARs; Padj. < 0.05) between remodeled non-failing patient hearts and healthy donor hearts. The acetylation level of the chromatin region correlated with its RNA polymerase II occupancy level and the mRNA expression level of its adjacent gene per sample. Annotated genes from DARs were enriched in disease-related pathways, including fibrosis and cell metabolism regulation. DARs that change in the same direction have a tendency to cluster together, suggesting the well-reorganized chromatin architecture that facilitates the interactions of regulatory domains in response to myocardial remodeling. We further show the differences between the acetylation level and the mRNA expression level of cell-type-specific markers for cardiomyocytes and 11 non-myocyte cell types. Notably, we identified transcriptome factor (TF) binding motifs that were enriched in DARs and defined TFs that were predicted to bind to these motifs. We further showed 64 genes coding for these TFs that were differentially expressed in remodeled myocardium when compared with controls. Conclusions: Our study reveals extensive novel insight on myocardial remodeling at the DNA regulatory level. Differences between the acetylation level and the transcriptional level of cell-type-specific markers suggest additional mechanism(s) between acetylome and transcriptome. By integrating these two layers of epigenetic profiles, we further provide promising TF-encoding genes that could serve as master regulators of myocardial remodeling. Combined, our findings highlight the important role of chromatin regulatory signatures in understanding disease etiology.es_ES
dc.description.sponsorshipThis work was supported by the Netherlands Foundation for Cardiovascular Excellence (to C.C.), the NWO VENI grant (no. 016.176.136 to M.H.), two NWO VIDI grants (no. 91714302 to C.C. and no. 016096359 to M.C.V), the Erasmus MC fellowship grant (to C.C.), the RM fellowship grant of the UMC Utrecht (to C.C.), Wilhelmina Children’s Hospital research funding (no. OZF/14 to M.H.), the Netherlands Cardiovascular Research Initiative: An initiative with the support of the Dutch Heart Foundation (CVON2014-40 DOSIS: to J.P., M.H., F.W.A., and CVON2014-11 RECONNECT: to C.C., M.C.V., G.P., M.M., D.D.), and the Dutch Heart Foundation (Queen of Heart: to C.C., H.D.R., M.C.V, G.P.), UCL Hospitals NIHR Biomedical Research Centre (to F.W.A.), the doctoral research fellowships by the National Institute of Health Research (NIHR; DRF2013-06-102 to T.A.T.), and National Institutes of Health (USA) grant LM010098 (to J.H.M.).es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectMyocardial remodelinges_ES
dc.subjectHistone acetylationes_ES
dc.subjectTranscriptomees_ES
dc.subjectTranscription factores_ES
dc.titleH3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human heartses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.es_ES
dc.editorial.noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.es_ES
dc.identifier.doi10.1186/s13148-020-00895-5-
dadun.citation.number106es_ES
dadun.citation.publicationNameClinical Epigeneticses_ES
dadun.citation.volume12es_ES

Ficheros en este ítem:
Vista previa
Fichero
s13148-020-00895-5.pdf
Descripción
Tamaño
3.47 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.